Browse by Tags

An oral treatment of harmless, specially engineered gut bacteria was able to reverse type 1 diabetes (T1D) in experimental mice, according to a partially JDRF-funded study in Belgium. The findings , which were recently published in the April edition of the Journal of Clinical Investigation , may hold...

As we inch toward the end of 2011, a look back over the past few months shows a great deal of progress in JDRF’s efforts toward curing, treating, and preventing type 1 diabetes (T1D) and its complications. Check out the latest key advances from the first quarter of fiscal year 2012 (July through...

A new study by the University of Texas Southwestern (UTSW) Medical Center in Dallas suggests that an excess of glucagon, rather than a shortage of insulin, is the main culprit in diabetes. Glucagon is a pancreatic hormone that raises low blood sugar in healthy individuals, but whose excess in those with...

Researchers recently reported that a drug commonly used to reduce blood sugar in people with type 2 diabetes may also have similar effects for people with type 1, a finding that could add to the pool of possible new treatments to help people with type 1 diabetes better manage the disease. A pilot study...

While a cure is the ultimate goal, finding better ways to treat type 1 diabetes today is a priority throughout the research community. And developing new and more effective insulins is a particularly active area for research on better treatments. Earlier this month at the European Association for the...